Long-term survival in a randomized study of nonplatinum therapy versus platinum in advanced epithelial ovarian cancer

M. O. Nicoletto, S. Tumolo, R. Sorio, G. Cima, L. Endrizzi, O. Nascimben, O. Vinante, G. Artioli, M. Donach, G. Cartei

Research output: Contribution to journalArticlepeer-review

Abstract

The purpose of this study was to compare long-term survival in first-line chemotherapy with and without platinum in advanced-stage ovarian cancer. From July 1987 to November 1992, 161 untreated patients with FIGO stage III-IV epithelial ovarian cancer were randomized: 81 patients received no platinum and 80 received platinum combination. Residual disease after surgery was

Original languageEnglish
Pages (from-to)986-992
Number of pages7
JournalInternational Journal of Gynecological Cancer
Volume17
Issue number5
DOIs
Publication statusPublished - Sep 2007

Keywords

  • First-line
  • Long-term survival
  • Ovarian cancer
  • Platinum
  • Randomized

ASJC Scopus subject areas

  • Obstetrics and Gynaecology
  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Long-term survival in a randomized study of nonplatinum therapy versus platinum in advanced epithelial ovarian cancer'. Together they form a unique fingerprint.

Cite this